Evidence, thus, supports the associations of RECQL4, MXD3, BIRC5, and SNHG10 with TP53 mutant (Figure 7C) as a contributing factor to their potential in predicting ACC progression and prognosis. Here, MXD3 is linked to adrenal cortex carcinoma.